Stephen Foley: ObamaCare is bad news for Big Pharma


US Outlook: It has been a delight to see the good citizens of the UK getting all atwitter in defence of the National Health Service, in the face of so much bad-mouthing here in the US. If you can find an American, and disabuse them of the notion that the British government runs "death panels" that decide who gets life-saving treatment, that might help bring the healthcare debate here back into the realm of the real.

I still can't quite get my head around the idea we have to weigh our health against our wallets in this country, but this is the system that opponents of change say is the best in the world, despite all statistical evidence to the contrary.

It is certainly the best system in the world for the healthcare companies, whose margins in the US are fatter than they are anywhere else. Two of the UK's biggest firms, the pharmaceuticals companies GlaxoSmithKline and AstraZeneca, get around 40 per cent of their revenues from the US, making them critical players in the debate here – and meaning that the outcome of Barack Obama's fight for reform has some significant financial implications for UK shareholders.

The pharmaceuticals industry thinks it is playing a canny game. Early on, via its US lobby group PhRMA, it shook hands on a deal with the White House, pledging to cut the costs of drugs for senior citizens on federal health insurance by a total of $80bn (£48bn), and promising not to fund anti-reform ads as they have done in the past.

In return, they got what looks to some Democrats like an impressive list of concessions. There will be no congressional or White House push to allow the importation of cheaper drugs from Canada, and no other federal pressure for rebates that could push the cost of reform to the industry above that $80bn. With these promises in the bank, investors in drug firms rather think that the expansion of health insurance will actually lead to more people using their products, which would more than make up for the loss of margin.

Actually, the drug firms are much more likely to be losers – and not just because the pact with the White House is showing signs of breaking down. Within weeks the President suggested that he might be able to negotiate more than the $80bn from the industry, and as more details of the secret deal have leaked this week, anger among congressional Democrats has prompted even more equivocation from the White House.

Even if President Obama cuts the drug industry loose, as long as he does it at the last minute, when there will be no time left to lobby, he will have achieved his objective of neutering the industry.

There's a whole list of other worries for the world's largest pharmaceuticals companies, all stemming from the fact that President Obama is fixated on getting the cost of healthcare down. One way or another, that means slimmer margins for GlaxoSmithKline, AstraZeneca and their rivals. The betting is still that health insurance reform will pass in some form, either with a government-run scheme that will pull in people who fall out of employee-sponsored plans, or private-sector cooperatives. Whichever is the case, there ought to be big new players in what is currently a fragmented market, whose buying power can help drive down the cost of medicines.

And, before the current healthcare legislation began to take shape, another major development occurred that increasingly worries pharmaceuticals executives. The federal government this year set aside $1.1bn to fund "comparative effectiveness research". This will go towards studying whether expensive brand-name medicines are really any better than generic copies, and preventing the wasteful use of drugs that might prove to be ineffective on some types of patient.

Most importantly, the research will be a useful counter to Big Pharma-funded research studies, and the boondoggle propaganda of their super-remunerated salesforces.

The pharmaceuticals giants are switching their expansion plans as fast as they can to emerging markets, where richer populations are spending more on health. The trouble is, profits look set to erode faster in their largest market.

Life and Style
A teenager boy wakes up.
life
Life and Style
It is believed that historically rising rates of alcohol consumption have contributed to the increase
food + drink
News
An Apple iPhone 6 stands on display at the Apple Store
businessRegulators give iPhone 6 and 6 Plus the green light
Arts and Entertainment
Critics say Kipling showed loathing for India's primitive villagers in The Jungle Book
filmChristopher Walken, Bill Murray, Scarlett Johanssen Idris Elba, Andy Serkis, Benedict Cumberbatch, Cate Blanchett and Christian Bale
PROMOTED VIDEO
Life and Style
Playing to win: for Tanith Carey, pictured with Lily, right, and Clio, even simple games had to have an educational purpose
lifeTanith Carey explains what made her take her foot off the gas
Arts and Entertainment
film
Arts and Entertainment
The White Sails Hospital and Spa is to be built in the new Tunisia Economic City.
architectureRussian billionaire designs boat-shaped hospital for new Dubai-style Tunisia Economic City
Life and Style
tech
Extras
indybest
Arts and Entertainment
A still from Duncan Campbell's hour-long film 'It for Others'
Turner Prize 2014
Life and Style
food + drink
News
i100
Arts and Entertainment
Tony Hadley in a scene from ‘Soul Boys Of The Western World’
musicSpandau Ballet are back together - on stage and screen
News
ebooksAn unforgettable anthology of contemporary reportage
News
i100
Life and Style
Bearing up: Sebastian Flyte with his teddy Aloysius in Brideshead Revisited
lifePhilippa Perry explains why a third of students take a bear to uni
Arts and Entertainment
Sir Alan Sugar appearing in a shot from Apprentice which was used in a Cassette Boy mashup
artsA judge will rule if pieces are funny enough to be classed as parodies
Arts and Entertainment
film
News
news
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Trust Accountant - Kent

NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...

Graduate Recruitment Consultant - 2013/14 Grads - No Exp Needed

£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...

Law Costs

Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...

SQL Developer (Stored Procedures) - Hertfordshire/Middlesex

£300 - £330 per day: Ashdown Group: SQL Developer (Stored Procedures) Watford...

Day In a Page

Isis is an hour from Baghdad, the Iraq army has little chance against it, and air strikes won't help

Isis an hour away from Baghdad -

and with no sign of Iraq army being able to make a successful counter-attack
Turner Prize 2014 is frustratingly timid

Turner Prize 2014 is frustratingly timid

The exhibition nods to rich and potentially brilliant ideas, but steps back
Last chance to see: Half the world’s animals have disappeared over the last 40 years

Last chance to see...

The Earth’s animal wildlife population has halved in 40 years
So here's why teenagers are always grumpy - and it's not what you think

Truth behind teens' grumpiness

Early school hours mess with their biological clocks
Why can no one stop hackers putting celebrities' private photos online?

Hacked photos: the third wave

Why can no one stop hackers putting celebrities' private photos online?
Royal Ballet star dubbed 'Charlize Theron in pointe shoes' takes on Manon

Homegrown ballerina is on the rise

Royal Ballet star Melissa Hamilton is about to tackle the role of Manon
Education, eduction, education? Our growing fascination with what really goes on in school

Education, education, education

TV documentaries filmed in classrooms are now a genre in their own right
It’s reasonable to negotiate with the likes of Isis, so why don’t we do it and save lives?

It’s perfectly reasonable to negotiate with villains like Isis

So why don’t we do it and save some lives?
This man just ran a marathon in under 2 hours 3 minutes. Is a 2-hour race in sight?

Is a sub-2-hour race now within sight?

Dennis Kimetto breaks marathon record
We shall not be moved, say Stratford's single parents fighting eviction

Inside the E15 'occupation'

We shall not be moved, say Stratford single parents
Air strikes alone will fail to stop Isis

Air strikes alone will fail to stop Isis

Talks between all touched by the crisis in Syria and Iraq can achieve as much as the Tornadoes, says Patrick Cockburn
Nadhim Zahawi: From a refugee on welfare to the heart of No 10

Nadhim Zahawi: From a refugee on welfare to the heart of No 10

The Tory MP speaks for the first time about the devastating effect of his father's bankruptcy
Witches: A history of misogyny

Witches: A history of misogyny

The sexist abuse that haunts modern life is nothing new: women have been 'trolled' in art for 500 years
Shona Rhimes interview: Meet the most powerful woman in US television

Meet the most powerful woman in US television

Writer and producer of shows like Grey's Anatomy, Shonda Rhimes now has her own evening of primetime TV – but she’s taking it in her stride
'Before They Pass Away': Endangered communities photographed 'like Kate Moss'

Endangered communities photographed 'like Kate Moss'

Jimmy Nelson travelled the world to photograph 35 threatened tribes in an unashamedly glamorous style